256
Views
11
CrossRef citations to date
0
Altmetric
Review

Transdermal natural progesterone cream for postmenopausal women: Inconsistent data and complex pharmacokinetics

&
Pages 655-659 | Published online: 02 Jul 2009

References

  • Drug and Therapeutics Bulletin. ‘Natural’ progesterone creams for postmenopausal women. Drug and Therapeutics Bulletin 2001; 39: 10–11
  • Barengolts E I, Gajardo H F, Rosol T J, D'Anza J J, Pena M, Botsis J, et al. Effects of progesterone on postovariectomy bone loss in aged rats. Journal of Bone and Mineral Research 1990; 5: 1143–1147
  • Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
  • Burry K A, Patton P E, Hermsmeyer K. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal oestrogen. American Journal of Obstetrics and Gynecology 1999; 180: 1504–1511
  • Carey B J, Carey A H, Patel S, Carter G, Studd J W. A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women. British Journal of Obstetrics and Gynaecology 2000; 107: 722–726
  • Cooper A, Spencer C, Whitehead M I, Ross D, Barnard G J, Collins W P. Systemic absorption of progesterone from Progest cream in postmenopausal women. Lancet 1998; 351: 1255–1256
  • DeVenuto F. Interaction of progesterone and aldosterone with red blood cells of the rat. Proceedings of the Society for Experimental Biology and Medicine 1967; 124: 478–483
  • Devenuto F, Ligon D F, Friedrichsen D H, Wilson H L. Human erythrocyte membrane. Uptake of progesterone and chemical alterations. Biochimica et Biophysica Acta 1969; 193: 36–47
  • Ferenczy A, Gelfand M M, Tzipris F. The cytodynamics of endometrial hyperplasia and carcinoma. A review. Annals of Pathology 1983; 3: 189–201
  • Fisher G J, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Archives of Dermatology 2002; 138: 1462–1470
  • Gilchrest B A. A review of skin ageing and its medical therapy. British Journal of Dermatology 1996; 135: 867–875
  • Graham J D, Clarke C L. Physiological action of progesterone in target tissues. Endocrine Reviews 1997; 18: 502–519
  • Henriet P, Cornet P B, Lemoine P, Galant C, Singer C F, Courtoy P J, et al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs). Annals of the New York Academy of Science 2002; 955: 119–138, discussion 157 – 158, 396 – 406
  • Henry F, Pierard-Franchimont C, Cauwenbergh G, Pierard G E. Age-related changes in facial skin contours and rheology. Journal of the American Geriatric Society 1997; 45: 220–222
  • Hermann A C, Nafziger A N, Victory J, Kulawy R, Rocci M L, Jr, Bertino J S, Jr. Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product. Journal of Clinical Pharmacology 2005; 45: 614–619
  • Hirvonen E, Malkonen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. New England Journal of Medicine 1981; 304: 560–563
  • Holzer G, Riegler E, Honigsmann H, Farokhnia S, Schmidt J B. Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomised study. British Journal of Dermatology 2005; 153: 626–634
  • Hueber F, Besnard M, Schaefer H, Wepierre J. Percutaneous absorption of estradiol and progesterone in normal and appendage-free skin of the hairless rat: lack of importance of nutritional blood flow. Skin Pharmacology 1994a; 7: 245–256
  • Hueber F, Schaefer H, Wepierre J. Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacology 1994b; 7: 237–244
  • Im S, Lee E S, Kim W, Song J, Kim J, Lee M, et al. Expression of progesterone receptor in human keratinocytes. Journal of Korean Medical Science 2000; 15: 647–654
  • Koefoed P, Brahm J. The permeability of the human red cell membrane to steroid sex hormones. Biochimica et Biophysica Acta 1994; 1195: 55–62
  • Kowalski W B, Chatterton R T, Jr, Kazer R R, Severini T A. Disappearance and unexpected reappearance of progesterone in the circulation of the monkey: novel hormone kinetics. Journal of Physiology 1996; 493(Pt 3)877–884
  • Lane G, Siddle N C, Ryder T A, Pryse-Davies J, King R J, Whitehead M I. Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium. British Medical Journal 1983; 287: 1241–1245
  • Lee J R. Osteoporosis reversal with transdermal progesterone. Lancet 1990a; 336: 1327
  • Lee J R. Osteoporosis reversal. The role of progesterone. International Clinical Nutrition Reviews 1990b; 10: 384–391
  • Lee J R. Natural progesterone: The multiple roles of a remarkable hormone. BLL, Sebastopol 1995
  • Lee J R. Use of Pro-Gest cream in postmenopausal women. Lancet 1998; 352: 905–906
  • Leonetti H B, Longo S, Anasti J N. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstetrics and Gynecology 1999; 94: 225–228
  • Leonetti H B, Wilson K J, Anasti J N. Topical progesterone cream has an antiproliferative effect on oestrogen-stimulated endometrium. Fertility and Sterility 2003; 79: 221–222
  • Lewis J G, McGill H, Patton V M, Elder P A. Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women. Maturitas 2002; 41: 1–6
  • Li X, Chen C, Singh S M, Labrie F, Labire F. The enzyme and inhibitors of 4-ene-3-oxosteroid 5 alpha-oxidoreductase. Steroids 1995; 60: 430–441
  • Lin T J, Billiar R B, Little B. Metabolic clearance of progesterone in the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1972; 35: 879–886
  • Lydeking-Olsen E, Beck-Jensen J E, Setchell K D, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss – a 2 year randomized, placebo-controlled trial. European Journal of Nutrition 2004; 43: 246–257
  • Mercier I, Colombo F, Mader S, Calderone A. Ovarian hormones induce TGF-beta(3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovascular Research 2002; 53: 728–739
  • Norman T R, Morse C A, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertility and Sterility 1991; 56: 1034–1039
  • O'Leary P, Feddema P, Chan K, Taranto M, Smith M, Evans S. Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre-and postmenopausal women. Clinical Endocrinology (Oxf) 2000; 53: 615–620
  • Padwick M L, Endacott J, Matson C, Whitehead M I. Absorption and metabolism of oral progesterone when administered twice daily. Fertility and Contraception 1986; 46: 402–407
  • Prior J C. Progesterone as a bone-trophic hormone. Endocrinology Reviews 1990; 11: 386–398
  • Rittie L, Fisher G J. UV-light-induced signal cascades and skin aging. Ageing Research Reviews 2002; 1: 705–720
  • Schmidt J B, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecologic and Obstetric Investigation 1990; 30: 97–100
  • Tan C Y, Statham B, Marks R, Payne P A. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. British Journal of Dermatology 1982; 106: 657–667
  • Tremollieres F A, Strong D D, Baylink D J, Mohan S. Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production. Acta Endocrinologica (Copenh) 1992; 126: 329–337
  • Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime. British Journal of Obstetrics and Gyanecology 2005a; 112: 1402–1406
  • Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal oestrogen. Gynecological Endocrinology 2005b; 21: 101–105
  • Waddell B J, O'Leary P C. Distribution and metabolism of topically applied progesterone in a rat model. Journal of Steroid Biochemistry and Molecular Biology 2002; 80: 449–455
  • Weiderpass E, Adami H O, Baron J A, Magnusson C, Bergstrom R, Lindgren A, et al. Risk of endometrial cancer following oestrogen replacement with and without progestins. Journal of the National Cancer Institute 1999; 91: 1131–1137
  • Wren B G, Champion S M, Willetts K, Manga R Z, Eden J A. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause 2003; 10: 13–18
  • Wren B G, McFarland K, Edwards L, O'Shea P, Sufi S, Gross B, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000; 3: 155–160

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.